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Gout is a disorder of uric-acid metabolism. The Paciﬁc Austronesian population, including Taiwanese aborigines,
has a remarkably high prevalence of hyperuricemia and gout, which suggests a founder effect across the Paciﬁc
region. We report here a genomewide linkage study of 21 multiplex pedigrees with gout from an aboriginal tribe
in Taiwan. From observations of familial clustering, early onset of gout, and clinically severe manifestations, we
hypothesized that a major gene plays a role in this trait. Using 382 random polymorphic markers spread across
22 autosomes, we demonstrated a highly signiﬁcant linkage for gout at marker D4S2623 on chromosome 4q25
( by nonparametric linkage [the NPLall statistic]; empirical ; , by
56Pp .0002 Pp .0006 LODp 4.3 Pp 4.4 # 10
logistic regression). When alcohol consumption was included as a covariate in the model, the LOD score increased
to 5.66 ( ). Quantitative traits, including serum uric acid and creatinine, also showed a moderate56Pp 1.3 # 10
linkage to this region. To our knowledge, this is the ﬁrst genome-scan report to identify a genetic locus harboring
a gout-susceptibility gene.
Gout (MIM 138900) is characterized by elevated serum
urate and recurrent attacks of intra-articular crystal dep-
osition of monosodium urate monohydrate. Clinical
manifestations include recurrent painful attacks of acute
inﬂammatory arthritis, tophi, uric-acid urolithiasis, renal
impairment, and, eventually, renal failure. Uric acid is
produced within all mammalian cells as the product of
purine degradation. Homeostasis of uric acid depends
on the balance between cellular production and renal
clearance. Hyperuricemia develops as the result of over-
production or decreased renal excretion of uric acid. The
incidence of acute gout is ∼5% each year among patients
with hyperuricemia and a serum-urate concentration of
9.0 mg/dl (Campion et al. 1987). Gout has genetic com-
ponents and is complicated by environmental factors,
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such as diet and alcohol intake, and by age and sex.
Most genetic ﬁndings are derived from rare forms of
Mendelian disorders—for example, hypoxanthine gua-
nine phosphoribosyltransferase (HPRT) related to X-
linked gout, autosomal dominant medullary cystic kid-
ney disease (ADMCKD) on chromosome 1q21, familial
juvenile hyperuricemic nephropathy on chromosome 16,
uric-acid nephrolithiasis on chromosome 10, or genes
for uric-acid transport in the kidney (see entry for MIM
138900).
A series of studies on indigenous groups from Poly-
nesia (Jackson et al. 1981; Prior et al. 1987; Prigent et
al. 1992), Melanesia (Prior 1981), Micronesia (Zimmet
et al. 1978), Indonesia (Darmawan et al. 1992), and
Taiwan (Chang et al. 1997) show uric-acid levels sig-
niﬁcantly higher than those found in white populations.
Linguistic, archaeological, and genetic evidence suggests
that the insular populations across the Paciﬁc region,
including Polynesians, Micronesians, Melanesians, and
Taiwan aborigines, are part of an Austronesian popu-
lation (Bellwood 1991; Diamond 2000; Gray and Jordan
2000; Chang et al. 2002; Diamond and Bellwood 2003).
This genetic relationship and the high morbidity of gout
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Table 1
Characteristics of Subjects with Gout and Unaffected Subjects from 21 Multiplex Aboriginal
Families in Taiwan
CHARACTERISTIC
FINDING IN
P
Subjects with Gout
( )np 91
Unaffected Subjects
( )np 63
Age (years) 47.3  14.9 46.9  15.0 .90
No. who consume alcohol:
Regularly 56 27 .02
Rarely 35 36 …
Age (years) at start of alcohol consumption 21.87  6.5 23.2  7.3 .57
No. of years of alcohol consumption 20.2  10.2 23.3  17.0 .46
BMI (kg/m2) 25.4  4.1 25.5  4.2 .99
Uric acid (mg/dL) 9.5  2.4 7.6  1.8 !.001
Blood pressure (mmHg):
Systolic 136.4  23.2 127.7  24.2 .028
Diastolic 87.9  15.5 82.3  15.1 .029
Triglyceride (mg/dL) 265.8  240.7 207.8  120.3 .053
Cholesterol (mg/dL) 190.3  45.3 176.6  27.1 .022
Liver function (IU/L):
GOT 30.9  27.2 27.7  15.4 .40
GPT 29.6  20.4 27.4  24.9 .54
in these Austronesian populations suggest a possible
founder effect of gout susceptibility. Without a priori
knowledge of the predisposing genes for the complex
primary gout disease, we conducted a genomewide link-
age study on 21 multiplex pedigrees with gout from an
isolated highland aboriginal tribe in Taiwan, with the
rationale that this population is presumably more ho-
mogeneous than other populations and, thus, provides
a better power to illustrate genetic effects (Wright et al.
1999).
The ascertainment of the gout probands was initially
done in a community public-health survey conducted in
the local health stations in Taiwan, with the aim of
health education and prevention. The general health his-
tory and speciﬁc conditions, including gout and hyper-
tension, of middle-aged and elderly people were re-
corded. The diagnosis of the proband with gout was
conﬁrmed by a rheumatologist on the basis of criteria
from Wallace et al. (1977). Family structure and the
family history of each proband were obtained in the
survey. All affected members reported by the probands
were conﬁrmed by the rheumatologist. Blood was drawn
by trained medical technologists. Informed consent from
each study subject was obtained before the study. In
total, we recruited 154 individuals from 21 pedigrees.
Genomic DNA was prepared from blood with the
PureGene DNA isolation kit (Gentra Systems). Geno-
typing was provided by theMammalian Genotyping Ser-
vice of the Marshﬁeld Clinic Research Foundation. The
samples were genotyped using the newer screening set,
Weber Screening Set 13 (see the Center for Medical Ge-
netics Web site), which has more-accurate allele calling
and less error or mistyping as a consequence of its use
of higher-quality tri- and tetranucleotide STRPs with
more accurate mapping and spacing (Ghebranious et al.
2003). In this study, 382 autosomal markers were used,
with an average of 9.3-cM spacing (range 0.3–18 cM)
and 0.69 heterozygosity.
We applied PedCheck (O’Connell and Weeks 1998)
and MERLIN (Abecasis et al. 2002) software to check
for any inconsistent Mendelian inheritance, nonpatern-
ity, or other genotyping errors. Any inconsistency was
zeroed out to avoid bias. We removed three individuals
from analysis because of many genotyping errors found
in the samples. Gene frequencies were estimated by allele
counting in all genotyped individuals and were auto-
matically calculated by MERLIN. The results were not
different when we used other strategies to calculate allele
frequency, such as the maximum-likelihood estimate.
For discrete traits, we ﬁrst performed nonparametric
linkage (NPL) (Whittemore and Halpern 1994) with the
use of MERLIN. This method calculates inheritance dis-
tribution for sets of affected pairs and then uses a score
function to determine the significance of linkage. We
used the NPLall statistic, which estimates identical-by-
descent (IBD) allele sharing among all affected members
and is averaged over all possible inheritance patterns,
normalized, and weighted across pedigrees. Because
some of our pedigrees are complicated and their infor-
mation may not be fully utilized by the NPL statistics,
we applied another multipoint analysis using the con-
ditional-logistic model (Olson 1999) implemented in the
S.A.G.E. program package. This method estimates b pa-
rameters on the basis of li, the relative risk for a pair
of relatives that shares i alleles IBD, where .Mul-bil p ei
tipoint IBD estimates were obtained using the GENIBD
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Figure 1 Multipoint linkage analysis using NPL in the genomewide scan on multiplex Taiwanese aboriginal families with gout. The X-
axis represents the chromosome location for the 22 autosomes, and the Y-axis represents the , where P is derived from the NPLall statistic. logP
The best peak is on chromosome 4, with (NPL ). logPp 3.70 Zp 3.58
program in S.A.G.E. We used a one-parameter model
and the default value that constrains the relative risks,
, without assuming any mode ofl p 3.634l  2.6342 1
inheritance. The likelihood-ratio statistic (LRS) is com-
puted by multiplying the LOD score by 4.6. The P value
for the one-parameter model is derived from the LRS
distribution with 50:50 mixture of a point mass at 0
and a 1-df x2 distribution. When alcohol consumption
was included in the model, the LRS distribution was a
50:50 mixture of a x2 with 1 df and a x2 with 2 df
(Goddard et al. 2001). The signiﬁcance of the covariate
is determined by the difference between the LRS with
the covariate and the LRS without the covariate.
For quantitative-trait linkage analysis, we applied the
Deviate method in MERLIN to test for excess sharing
among individuals in the same tail of trait distribution,
without making the normality assumption of the trait
distribution. This method is based on the frameworks
of Whittemore and Halpern (1994) and Kong and Cox
(1997) to deﬁne a score function and to test the signif-
icance of linkage. The quantitative phenotype was sub-
tracted from the population mean, which was based on
an epidemiological survey of the same aboriginal tribe
for the biochemical measurements.
To examine the false-positive rate in the genome scan,
we performed 10,000 multipoint simulations under the
null hypothesis of no linkage or association to the phe-
notype, by use of MERLIN. The simulation generates
random marker data sets that use the original data—
including family structure, phenotypes, marker inform-
ativeness, map distance, and missing-data patterns—
without simulating their value, through gene-dropping
procedures (Abecasis et al. 2002). Empirical P is deter-
mined by the number of replicates that exceed the ob-
served Z score, divided by the total number of replicates
(10,000).
Among 21 families, 1 extended pedigree was too big
to ﬁt the software we used; therefore, we divided this
pedigree into 3 families for the conditional-logistic
model (LODPAL in S.A.G.E.) or into 5 families for NPL
(MERLIN). Among the 23 pedigrees that were analyzed
by the logistic model, there was a total of 66 affected
sib pairs, 30 affected parent-child pairs, 4 affected half-
sib pairs, 14 affected grandparent-grandchild pairs, 61
affected avuncular pairs, and 29 affected cousin pairs.
We found no signiﬁcant difference in age between the
group with gout and the unaffected group (table 1).
More subjects with gout consumed alcohol on a regular
basis (at least twice a week) than did unaffected subjects.
However, starting age and duration of alcohol con-
sumption and liver function measurements (glutamic-
oxaloacetic transaminase [GOT] and glutamic-pyruvic
transaminase [GPT]) did not differ from those of the
unaffected subjects. The affected group also had higher
blood pressure and higher levels of serum uric acid and
cholesterol than those of the unaffected group. No sig-
niﬁcant difference was found in BMI between the af-
fected and unaffected groups.
With error-checked genotype data on 382 autosomal
markers, we ﬁrst applied multipoint NPL analysis based
on IBD sharing among affected relative pairs, using all
marker information in each chromosome to screen all
22 chromosomes for linkage results. We chose NPLall to
estimate allele sharing among all affected members to-
gether. Figure 1 shows the NPL Z score obtained from
MERLIN for all 22 chromosomes. The highest NPL Z
score (3.58) among the 22 chromosomes scanned was
located at 114 cM on chromosome 4, with a P value of
.0002 (ﬁg. 1). The empirical P value was .0006.
We next applied an alternative approach, to further
conﬁrm the ﬁndings on chromosome 4. We chose the
conditional-logistic model because this approach is par-
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Figure 2 Multipoint linkage analysis on chromosome 4, cal-
culated by the conditional-logistic model. The X-axis is the chromo-
some location (cM), and the Y-axis is the LOD score calculated from
the logistic model. The peak location is at marker D4S2623.
Table 2
Linkage Results of Gout and Its Quantitative Traits on Chromosome 4 (at
Position 114 cM), by Different Statistical Methods
Trait Method LOD Score P
Gout Conditional-logistic model 4.29 .0000044
Gout with covariatea Conditional-logistic model 5.66 .0000013
Gout NPLb 3.58 .0002c
Uric acid Deviated 1.11 .012c
Creatinine Deviated 1.47 .005c
a Alcohol consumption was added in binary form as a covariate in the one-
parameter logistic model.
b NPL score implemented in MERLIN.
c Empirical P values, based on 10,000 simulations and calculated by MER-
LIN, were .0006 for gout, .0414 for uric acid, and .0197 for creatinine.
d Deviate method developed by Abecasis et al. (2002) and implemented in
MERLIN.
ameterized in terms of the allele-sharing–speciﬁc relative
risks and may capture more information than the NPL
method. On the basis of the logistic model, the maximal
LOD score for chromosome 4 was located again at 114
cM ( ; ) (table 2 and ﬁg. 2).LODp 4.3 Pp .0000044
Because alcohol consumption plays a role in gout de-
velopment, we included it as a covariate in the logistic
model. The LOD score increased to 5.66, and the overall
P value for the linkage was .0000013 on the basis of a
mixture of 1-df and 2-df distributions. The alcohol con-
sumption was signiﬁcant, with ( , 12Pp .012 x p 6.30
df). The corresponding marker at this peak location was
D4S2623. The LOD score from single-point analysis for
this marker was 6.37, under a one-parameter model
(data not shown). The 1-LOD score support intervals
are from 107 cM to 129 cM. The estimate of b1 from
the one-parameter model with the alcohol-consumption
covariate was 0.99; thus, and .l p 2.68 l p 7.101 2
That is, the relative risk for an individual who shares
one allele IBD with an affected relative is almost 3, and
the relative risk for the person sharing two alleles IBD
with an affected relative is 17.
We also analyzed gout-related phenotypes to ﬁnd con-
sistent mapping with gout. We applied the Deviate
method in MERLIN to test for excess sharing among
individuals in the same tail of trait distribution for the
quantitative trait, because this method is not sensitive
to the assumption of trait distribution. The results
showed that QTL analysis coincidentally mapped to the
same location, at 114 cM on chromosome 4 (table 2).
For uric acid, the P value was .012, and for creatinine,
the P value was .005. We again performed 10,000 sim-
ulations for this analytical method. The empirical P was
.0414 for uric acid and .0197 for creatinine. We did not
ﬁnd evidence of linkage for blood pressure, BMI, tri-
glyceride, and alcohol consumption in this region.
The above results demonstrate that, with the use of
different analytical approaches and different traits, we
have identiﬁed a gout susceptibility locus on chromo-
some 4q25 through a genomewide search on an isolated
aboriginal tribe. The probability of type I error is very
trivial (!1/1,000 by empirical test), and the signiﬁcance
of linkage increased after we adjusted for the environ-
mental covariate effect. A genetic component of gout
has been suggested, but, to our knowledge, there was
no other report of signiﬁcant ﬁndings from linkage stud-
ies, except of some rare Mendelian syndromes, such as
ADMCKD or familial juvenile hyperuricemic nephro-
pathy. Studies failed to identify genes for the complex
trait gout from the systematic genome search, whichmay
be attributed to the heterogeneity of the disease and to
inadequate power of sample size, sample structure, or
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statistical methods. The present study has great power
because of both the multiplexity of the pedigree samples
and the unique nature of an isolated population. The
latter, presumably, is more homogeneous for genetic and
common environmental effects (Wright et al. 1999).
Therefore, we are able to localize the disease-suscepti-
bility locus from the genome search.
Previously, we conducted a genetic study on the same
tribe population (!10% of the samples used in the stud-
ies overlapped) to test a candidate region that was re-
portedly linked to an ADMCKD locus on chromosome
1q21 (Wang et al. 2004). From this region, nine markers
were tested on 112 sib pairs—including 50 concordantly
affected, 14 unaffected, and 48 discordant sib pairs—
among 25 pedigrees. A two-point sibpair regression
analysis revealed a marginally signiﬁcant linkage (Pp
) at the region 160–190 cM, and the family-.03–.003
association test detected a signiﬁcant excess transmission
of one allele at marker D1S484 (170 cM). The present
study, through a genome search, did not conﬁrm or rule
out the signiﬁcant linkage with this region in chromo-
some 1 (maximum LOD score is 1.01 by LODPAL and
0.97 by NPL, at 184 cM).
It is interesting that the strongest signal, at marker
D4S2623, located at 114 cM on the Marshﬁeld genetic
map, is ∼1.4 cM from a longevity locus (Puca et al.
2001). The coincidental mapping of a gout candidate
gene and a longevity gene implies either that this region
harbors two separate susceptibility genes, one for gout
and one for longevity, or that a common gene in this
region is responsible for both traits. Recently, Geesaman
et al. (2003) reported that the SNP markers of the gene
encoding microsomal triglyceride transfer protein
(MTP), among ∼50 putative genes in this 4q25 longev-
ity-locus area, was genetically associated with human
lifespan (Geesaman et al. 2003). They hypothesized that
the impact of MTP on human lifespan may be mediated
through its effects on the lipid proﬁle pathway. On the
other hand, uric acid scavenges potentially harmful re-
active oxygen species and has long been thought to be
a primary antioxidant in humans because of its high
levels in plasma, compared with those of other antiox-
idants (Ames et al. 1981). The positive correlation be-
tween lifespan and the concentration of uric acid in se-
rum and in brain, among mammalian species (Cutler
1984), suggests a role of uric acid in longevity. Whether
the MTP has a role in uric-acid metabolism or in gout
pathogenesis is unknown. MTP plays a role in lipid
transfer and the assembly of lipoproteins (Hussain et al.
2003). Dyslipidemia, including abnormalities in triglyc-
eride, low-density lipoprotein, and apoB, is comorbid
with gout or hyperuricemia (Chou and Chao 1999; Rott
and Agudelo 2003). It would be interesting to study the
possible interactions among MTP, lipids, the homeosta-
sis of uric acid, and the development of gout. Alterna-
tively, the hypothesis that a still-unidentiﬁed gene
within the longevity locus could affect both longevity
and gout phenotypes is also remotely possible. The iden-
tiﬁcation of a gout-susceptibility gene in the 4q25 region
may shed light on the pathogenesis of gout and possibly
on the mechanisms of longevity.
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